// App-Quantinova.ai

764 : No Impact of Prior DMARD Exposures on Mortality in US Veterans with Cancer Treated with Immune Checkpoint Inhibitors

Researchers

Presenter

  • Tawnie Braaten

Principal Investigators

  • Brian Sauer

  • Gary Kunkel

  • Jessica Walsh

  • Jorge Rojas

  • Bryant England

  • Joshua Baker

  • Grant Cannon

Medical Centers

  • University of Utah Hospitals and Clinics and VA Salt Lake City Health Care System, Salt Lake City, UT

  • PCMC, Salt Lake City, UTUniversity of Utah, Salt Lake City, UT

  • University of Utah, Salt Lake City, UT

  • George E. Wahlen Department of Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT

  • University of Nebraska Medical Center, Omaha, NE

  • University of Pennsylvania and Corporal Michael J. Crescenz VAMC, Philadelphia, PA, USA

  • Salt Lake City VA, Salt Lake City, UT,

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved